Sep 2026· Journal of Inflammation Research· Vol 19, pp. 1-13· 0 citations· 31 references
Medicine
TL;DR
Hs-CRP and ALB are independently and jointly associated with HF risk.
Abstract
Background Although elevated high-sensitivity C-reactive protein (hs-CRP) and lower albumin (ALB) are each associated with increased heart failure (HF) risk, and inflammation and hypoalbuminemia are correlated in HF patients, evidence on their joint associations with incident HF is lacking. While C-reactive protein to albumin ratio (CAR) has been associated with HF, it shows no advantage over CRP alone. We therefore aimed to examine the independent and joint associations of hs-CRP and ALB with incident HF and to compare their predictive value with CAR. Methods In this prospective observational cohort study, we included 61,488 participants from the Kailuan Study without HF at baseline. hs-CRP and ALB were measured in 2010, and participants were stratified into four groups according to hs-CRP (<2 or ≥2 mg/L) and ALB (<46.1 or ≥46.1 g/L), with 46.1 g/L representing the cohort median. Incident HF was identified through hospital records and insurance data. Cox models estimated hazard ratios (HRs), and predictive performance was assessed using the C-index, Net Reclassification Improvement (NRI), and Integrated Discrimination Improvement (IDI). Results Over 11.3 years of follow-up, 1444 participants (2.35%) developed HF. Significant additive interactions were observed between hs-CRP, ALB, and HF risk. Compared with normal hs-CRP and above-median ALB, elevated hs-CRP and below-median ALB were associated with a 2.01-fold higher HF risk (HR 2.01, 95% CI 1.73–2.34). Among the evaluated models, the model incorporating the joint hs-CRP-ALB classification had the highest numerical C-index (0.7803). Compared with the fully adjusted model, the NRI and IDI were 0.2496 and 0.0012, respectively. Conclusion Hs-CRP and ALB are independently and jointly associated with HF risk.
BACKGROUND
Systemic inflammation has been associated with heart failure (HF) development. C-reactive protein (CRP) is a sensitive marker of inflammation, but its prognostic association with incident HF remains incompletely defined. We explored whether persistent CRP elevation was associated with incident HF among adult...
M. Busti, L. Monzo, T. Rastogi et al.· International Journal of Car...· 0 citations
Background The neutrophil percentage-to-albumin ratio (NPAR) is a novel inflammatory marker. However, its prognostic role in acute heart failure (AHF) remains unclear. Methods This post hoc analysis included 4622 patients with AHF from a nationwide prospective cohort in China. The outcomes were all-cause mortality (ACM...
Zhan-Yuan Chen, Yu Wei, Yao-Yao Wang et al.· Journal of Inflammation Rese...· 0 citations
In COPD patients, the CALLY index exhibits a significant L-shaped association with incident depression risk, characterized by a pronounced protective effect below the identified threshold and a risk plateau above it, suggesting that the CALLY index may serve as a clinically accessible tool for depression risk stratific...
Yu-Shan Shi, Xian-Hai Chen, Yan Wang· Frontiers in Medicine· 0 citations
Aims Metabolic dysfunction, inflammation, and lipoprotein(a) [Lp(a)] reflect different biomarker domains associated with atherosclerotic cardiovascular disease (ASCVD) risk. We examined the individual and joint associations of the triglyceride–glucose (TyG) index, high-sensitivity C-reactive protein (hs-CRP), and Lp(a)...
Guan-Lin Chen, Yu-Long Lan, Dan Wu et al.· Frontiers in Endocrinology· 0 citations
MASLD significantly increases the risk of cardiovascular events and all-cause mortality (ACM). The impact of the C-reactive protein-triglyceride-glucose index (CTI) and its derivatives on mortality in the MASLD population remains unclear. This study aimed to investigate their associations with mortality in the MA...
Guang-Jie Tu, Hang Zhai, Jun-Ming Xu et al.· BMC Cardiovascular Disorders· 0 citations
Background: Albumin-based biomarkers have emerged as practical tools for prognostic assessment in coronary artery disease (CAD), but their comparative prognostic patterns and potential clinical utility have not been systematically evaluated. Methods: We performed a systematic review and meta-analysis of albumin-based b...
Yan-Wu Yang, Tian-Yi Qu, Yan Zhang et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.